OWLT
Owlet, Inc.
NYSE · Healthcare · Medical - Devices · US
$4.98
−0.99%Aug 14, 2026, 00:00 UTC
Owlet, Inc. elected Marc F. Stoll and Kurt Workman as Class II directors, effective August 12, 2026.
Aug 11, 2026, 22:16 UTC
Owlet, Inc. reported Q2 earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.05 per share, compared to a loss of $0.05 per share a year ago.
Jul 1, 2026, 00:00 UTC
Owlet, Inc. entered into a $25 million asset-based revolving credit facility with Wells Fargo Bank, National Association, maturing June 26, 2029.
Source: